SCHEMBL10731400

SCHEMBL10731400

Cc1c(Cl)ncn1-c1nccc2[nH]c(=O)ccc12

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 18/20 0.59
PDE3A Q14432 18/20 0.59
HCAR1 Q9BXC0 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10725842 0.86 PDE3B (0.61) PDE3BPDE3AHCAR1
SCHEMBL10729937 0.77 PDE3B (0.59) PDE3BPDE3A
SCHEMBL10730897 0.76 PDE3B (0.55) PDE3BPDE3AHCAR1
SCHEMBL10725695 0.75 PDE3B (0.64) PDE3BPDE3A
SCHEMBL10725055 0.74 PDE3B (0.60) PDE3BPDE3AHCAR1
SCHEMBL10726017 0.74 PDE3B (0.75) PDE3BPDE3AHCAR1
SCHEMBL10729985 0.74 PDE3B (1.00) PDE3BPDE3A
SCHEMBL10726035 0.73 PDE3B (0.53) PDE3BPDE3A
SCHEMBL10725071 0.73 PDE3B (0.62) PDE3BPDE3A
SCHEMBL10724665 0.73 PDE3B (0.61) PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4716170-A 5-[1H-(5-membered-N-aromatic heteryl)-1-yl]-1,6-naphthyridin-2(1H)-ones and their cardiotonic use STERLING DRUG INC. (US) 1987-12-29 US disclosed
US-4697021-A 1,6-dihydro-6-oxo-3-pyridinecarbonitriles, intermediates for cardiotonic agents STERLING DRUG INC. (US) 1987-09-29 US disclosed
US-4657915-A INOTROPIC AGENTS STERLING DRUG INC. (US) 1987-04-14 US disclosed
US-4634772-A 2-[2-(di-lower-alkylamino)-1-propenyl]-6-methoxy-3-pyridinecarbonitriles, intermediates for cardiotonic agents STERLING DRUG INC. (US) 1987-01-06 US disclosed
EP-0189853-A2 1,6-Naphthyridin-2(1H)-ones having cardiotonic activity and preparation STERLING DRUG INC. (US) 1986-08-06 EP disclosed